Aug 09, 2023 / 12:00PM GMT
Jon Young - Canaccord Genuity(Australia)Ltd-Analyst
Morning everyone, get to kick this off. So, thank you so much for joining us for the Canaccord's 43 Annual Global Growth Conference. I'm Jon Young, member of the MedTech research team here. And I have the pleasure of hosting AngioDynamics, our first chat today with us, Jim Clemmer, CEO, and Steve Trowbridge, CFO. On the format today is a brief overview presentation, and then we followed by a fireside Q&A session. And with that, I'd like to invite Jim to the podium. Thank you.
Jim Clemmer - AngioDynamics Inc - President & CEO
Great, and good morning. Thanks Jon, and thanks to Canaccord for inviting us to your conference. So let me tell you about AngioDynamics, but before I do, I'll remind you check your forward-looking statements, you know that everything I tell you today, will be our best projections of strategies and what we'll do, but I can't guarantee that everything will happen. So please understand the risks of investing.
So let me talk
AngioDynamics Inc at Canaccord Genuity Growth Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
